HCIA - dropped 27 today? Tomorrow's outlook!!! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : HCIA - dropped 27 today? Tomorrow's outlook!!!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Milk who wrote (216)	12/31/1998 12:03:00 AM
From: blankmind	Read Replies (1) of 226

- My newsletter, Prudent Spec, continues to love HCIA despite the stock price decline. Here's what the December issue says: - keep in mind the goal price is $16 - here goes: "There is finally some good news to report on HCIA Inc. (HCIA - $4.88), tonight's Hotline Special and a struggling health care information company. HCIA announced today the formation of a "multi-year strategic relationship with Bristol-Myers Squibb, in which the two companies will work together to develop innovative capabilities capitalizing upon U.S. healthcare data to support Bristol-Myers products and customers." HCIA CEO George Pillari said, "working with Bristol-Myers expands use of our clinical databases and analytical tools within the pharmaceutical industry. Our relationship is built around HCIA's core expertise in clinical data handling and database management." Although no other details were disclosed, such as the revenue HCIA might generate, we think it an excellent time to consider an investment in HCIA as the stock, which is down nearly 60% in price this year, trades near its lowest level since going public in 1995 and the valuation is extremely inexpensive. Now trading for 78% of sales, 47% of book value and five times cash flow, we would buy longterm-debt-free HCIA up to $8.00 as our three-to- five year target price is $16. While the company is currently losing money, recently announced additional cost-cutting measures are expected to restore "consistent profitability" in the near future, according to Mr. Pillari.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next